Telemetry Investments’s aTyr Pharma ATYR Stock Holding History

Telemetry Investments’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.37M	Buy	624,000 +131,500	+27%	+$310K	2.16%	5
2022 Q3	$1.48M	Buy	492,500 +45,500	+10%	+$152K	1.89%	6
2022 Q2	$1.26M	Buy	447,000 +164,580	+58%	+$595K	1.5%	8
2022 Q1	$1.51M	Buy	282,420 +105,638	+60%	+$599K	2.38%	6
2021 Q4	$1.32M	Buy	176,782 +11,464	+7%	+$95.7K	1.7%	9
2021 Q3	$1.5M	Sell	165,318 -13,990	-8%	-$83.7K	2.02%	8
2021 Q2	$875K	Buy	179,308 +61,088	+52%	+$260K	1.2%	28
2021 Q1	$526K	Buy	+118,220	New	+$556K	0.59%	65

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Telemetry Investments's ATYR Position: Q4 2022 in Review

Telemetry Investments increased its aTyr Pharma (ATYR) stake by 27% in Q4 2022, buying an estimated $310K and bringing the position to 624,000 shares worth $1.37M. The position accounts for 2.16% of the portfolio, ranked #5.

Telemetry Investments first reported a position in ATYR in Q1 2021 and has held it in 8 quarters since. The position peaked at $1.51M in Q1 2022. 36 funds tracked by Wall St. Rank hold ATYR as of Q4 2022.

Telemetry Investments held 624,000 shares of aTyr Pharma worth $1.37M as of Q4 2022.
Telemetry Investments bought 131,500 aTyr Pharma shares in Q4 2022, an estimated $310K.
aTyr Pharma made up 2.16% of Telemetry Investments's portfolio in Q4 2022, its #5 holding.
Telemetry Investments first reported a position in aTyr Pharma in Q1 2021 and has held it in 8 quarters since.
Telemetry Investments's aTyr Pharma position peaked at $1.51M in Q1 2022.
36 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.